pubmed-article:17349073 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17349073 | lifeskim:mentions | umls-concept:C0012155 | lld:lifeskim |
pubmed-article:17349073 | lifeskim:mentions | umls-concept:C0015677 | lld:lifeskim |
pubmed-article:17349073 | lifeskim:mentions | umls-concept:C0086582 | lld:lifeskim |
pubmed-article:17349073 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:17349073 | lifeskim:mentions | umls-concept:C0920563 | lld:lifeskim |
pubmed-article:17349073 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
pubmed-article:17349073 | lifeskim:mentions | umls-concept:C0009830 | lld:lifeskim |
pubmed-article:17349073 | lifeskim:mentions | umls-concept:C1705241 | lld:lifeskim |
pubmed-article:17349073 | lifeskim:mentions | umls-concept:C1550605 | lld:lifeskim |
pubmed-article:17349073 | lifeskim:mentions | umls-concept:C0456205 | lld:lifeskim |
pubmed-article:17349073 | lifeskim:mentions | umls-concept:C1705242 | lld:lifeskim |
pubmed-article:17349073 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:17349073 | pubmed:dateCreated | 2007-3-12 | lld:pubmed |
pubmed-article:17349073 | pubmed:abstractText | Several apo B polymorphic sites have been studied for their potential use as markers for CHD in the population and for potential gene-diet interactions. Our aim was to determine whether the presence of the -516C/T polymorphism in the APOB gene promoter modifies insulin sensitivity to dietary fat. We studied fifty-nine healthy volunteers (thirty men and twenty-nine women, thirty-six homozygotes for the -516C allele (C/C) (nineteen males and seventeen females) and twenty-three heterozygotes for the -516T allele (C/T) (eleven males and twelve females)). Subjects consumed three diets during the feeding study, 4 weeks each: an SFA-rich diet (38 % fat, 20 % SFA), followed by a carbohydrate (CHO)-rich diet (30 % fat, 55 % CHO) or a MUFA-rich diet (38 % fat, 22 % MUFA) following a randomised cross-over design. For each diet, we investigated peripheral insulin sensitivity with the insulin suppression test. Male carriers of the -516T allele showed a significantly greater decrease in steady-state plasma glucose concentrations when changing from the SFA-rich diet (9.18 (sd 1.35) mmol/l) to the MUFA (6.55 (sd 0.74) mmol/l) or the CHO (6.31 (sd 0.93) mmol/l) diets than did those who were homozygous for the C allele (P = 0.040). Furthermore, C/T subjects presented higher plasma NEFA values after consumption of the SFA diet compared with the MUFA and CHO diets (P = 0.001). This effect was not observed in females (P = 0.908). Our findings show that male carriers of the -516T allele, C/T, have a significant increase in insulin resistance after consumption of all diets, but the difference is more exaggerated after the SFA diet compared with the MUFA- and CHO-rich diets. | lld:pubmed |
pubmed-article:17349073 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17349073 | pubmed:language | eng | lld:pubmed |
pubmed-article:17349073 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17349073 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17349073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17349073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17349073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17349073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17349073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17349073 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17349073 | pubmed:month | Apr | lld:pubmed |
pubmed-article:17349073 | pubmed:issn | 0007-1145 | lld:pubmed |
pubmed-article:17349073 | pubmed:author | pubmed-author:FuentesFranci... | lld:pubmed |
pubmed-article:17349073 | pubmed:author | pubmed-author:MarínCarmenC | lld:pubmed |
pubmed-article:17349073 | pubmed:author | pubmed-author:GómezPurifica... | lld:pubmed |
pubmed-article:17349073 | pubmed:author | pubmed-author:López-Miranda... | lld:pubmed |
pubmed-article:17349073 | pubmed:author | pubmed-author:Pérez-Jiménez... | lld:pubmed |
pubmed-article:17349073 | pubmed:author | pubmed-author:Pérez-Martíne... | lld:pubmed |
pubmed-article:17349073 | pubmed:author | pubmed-author:OrdovásJosé... | lld:pubmed |
pubmed-article:17349073 | pubmed:author | pubmed-author:MorenoJuan... | lld:pubmed |
pubmed-article:17349073 | pubmed:author | pubmed-author:MorenoRafaelR | lld:pubmed |
pubmed-article:17349073 | pubmed:author | pubmed-author:RuanoJuanJ | lld:pubmed |
pubmed-article:17349073 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17349073 | pubmed:volume | 97 | lld:pubmed |
pubmed-article:17349073 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17349073 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17349073 | pubmed:pagination | 622-7 | lld:pubmed |
pubmed-article:17349073 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:meshHeading | pubmed-meshheading:17349073... | lld:pubmed |
pubmed-article:17349073 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17349073 | pubmed:articleTitle | The APOB -516C/T polymorphism is associated with differences in insulin sensitivity in healthy males during the consumption of diets with different fat content. | lld:pubmed |
pubmed-article:17349073 | pubmed:affiliation | Unit of Lipids and Atherosclerosis, Hospital Universitario Reina Sofía, Avda. Menéndez Pidal, s/n. 14004, Córdoba, Spain. pablopermar@yahoo.es | lld:pubmed |
pubmed-article:17349073 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17349073 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
pubmed-article:17349073 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:17349073 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:17349073 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
entrez-gene:338 | entrezgene:pubmed | pubmed-article:17349073 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17349073 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17349073 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17349073 | lld:pubmed |